Phase I trial of dose escalated whole liver irradiation (WLRT) with hepatic arterial (HA) fluorodeoxyuridine (FUDR)/leucovorin (LV)/streptozotocin (STZ) chemotherapy followed by chemoembolization with mitomycin C (MMC) for patients with neuroendocrine hepatic metastases.

被引：0
|
作者：
Shilkrut, Mark
Schipper, Matthew J.
Ensminger, William D.
Ben-Josef, Edgar
Lawrence, Theodore Steven
Feng, Mary Uan-Sian
机构：
[1] Univ Michigan Hlth Syst, Dept Radiat Oncol, Ann Arbor, MI USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Dept Internal Med, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14603
引用
收藏
页数：1
相关论文
共 5 条
  • [1] Phase I Trial of Dose-escalated Whole Liver Irradiation With Hepatic Arterial Fluorodeoxyuridine/Leucovorin and Streptozotocin Followed by Fluorodeoxyuridine/Leucovorin and Chemoembolization for Patients With Neuroendocrine Hepatic Metastases
    Shilkrut, Mark
    Sapir, Eli
    Hanasoge, Sheela
    Schipper, Matthew J.
    Normolle, Daniel P.
    Ben-Josef, Edgar
    Ensminger, William
    Lawrence, Theodore S.
    Feng, Mary
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (04): : 326 - 331
  • [2] Whole-liver irradiation with hepatic arterial floxuridine/leucovorin/streptozotocin followed by hepatic arterial floxuridine/leucovorin and chemoembolization with mitomycin C for patients with metastatic neuroendocrine tumors
    Shilkrut, Mark
    Hanasoge, Sheela
    Normolle, Daniel Paul
    Ben-Josef, Edgar
    Ensminger, William D.
    Lawrence, Theodore Steven
    Feng, Mary Uan-Sian
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] A phase I/II trial of chemoembolization with mitomycin C following hepatic arterial fluorodeoxyuridine/leucovorin and whole liver radiotherapy for patients with intrahepatic malignancies.
    McGinn, CL
    Robertson, JM
    Ensminger, WD
    Walker, SC
    Lawrence, TS
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 169 - 169
  • [4] Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer
    Kemeny, N.
    Capanu, M.
    D'Angelica, M.
    Jarnagin, W.
    Haviland, D.
    Dematteo, R.
    Fong, Y.
    ANNALS OF ONCOLOGY, 2009, 20 (07) : 1236 - 1241
  • [5] Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure
    Sato Y.
    Inaba Y.
    Ura T.
    Nishiofuku H.
    Yamaura H.
    Kato M.
    Takahari D.
    Tanaka T.
    Muro K.
    Journal of Gastrointestinal Cancer, 2018, 49 (2) : 132 - 137
1